Of the seven CLL patient cells tested, six responded to CNL as demonstrated by reduction in STAT3 phosphorylation and increased cell death on CNL treatment, while one patient sample was resistant to CNL treatment. The gene discussed is STAT3; the disease is B-cell chronic lymphocytic leukemia.